Jul 29 |
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 12, 2024
|
Jul 23 |
Lucid Diagnostics Announces Record Quarterly EsoGuardĀ® Test Volume
|
Jul 11 |
Lucid Diagnostics Launches New Corporate Website
|
Jul 2 |
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuardĀ® Esophageal Precancer Testing in a Screening Population
|
Jun 13 |
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
|
Jun 12 |
4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuardĀ® Esophageal Precancer Testing
|